InvestorsHub Logo

Insync_2000

05/23/20 12:46 PM

#275795 RE: rafunrafun #275791

Thanks for the insight. That would make it easier yet. No ANDA required, start a subsidiary and start selling as generic albeit authorized generic.

Point being that JT should be drawing the market's attention to alternative paths to success should the appeal fail and should they have to compete with generics in the US.

North had pointed out that JT did mentioned it in one of his Conference Calls. I must have missed it and I pay fairly close attention.

massulo52

05/23/20 6:21 PM

#275898 RE: rafunrafun #275791

Remember Amarin would be the only GENERIC LABELED FOR CVD INDICATION SO WITH ADVERTISING CUSTOMERS WOULD ASK FOR IT!!!!!!